Vaccines for Viral and Parasitic Diseases Produced with Baculovirus Vectors

Overview

Journal Adv Virus Res

Specialty Microbiology

Date 2006 Sep 26

PMID 16997013

Citations 30

Authors

Monique M van Oers

Affiliations

Soon will be listed here.

Abstract

The baculovirus-insect cell expression system is an approved system for the production of viral antigens with vaccine potential for humans and animals and has been used for production of subunit vaccines against parasitic diseases as well. Many candidate subunit vaccines have been expressed in this system and immunization commonly led to protective immunity against pathogen challenge. The first vaccines produced in insect cells for animal use are now on the market. This chapter deals with the tailoring of the baculovirus-insect cell expression system for vaccine production in terms of expression levels, integrity and immunogenicity of recombinant proteins, and baculovirus genome stability. Various expression strategies are discussed including chimeric, virus-like particles, baculovirus display of foreign antigens on budded virions or in occlusion bodies, and specialized baculovirus vectors with mammalian promoters that express the antigen in the immunized individual. A historical overview shows the wide variety of viral (glyco)proteins that have successfully been expressed in this system for vaccine purposes. The potential of this expression system for antiparasite vaccines is illustrated. The combination of subunit vaccines and marker tests, both based on antigens expressed in insect cells, provides a powerful tool to combat disease and to monitor infectious agents.

Citing Articles

Comprehensive Comparison of Baculoviral and Plasmid Gene Delivery in Mammalian Cells.

Toth M, Reithofer M, Dutra G, Pereira Aguilar P, Durauer A, Grabherr R Viruses. 2024; 16(3).

PMID: 38543791 PMC: 10974095. DOI: 10.3390/v16030426.

Effects of wasp () nest extracts on virus replication of nuclear polyhedrosis virus on cell culture.

Caldas A, Borcek Kasurka C, Erturk O Cytotechnology. 2024; 76(1):123-137.

PMID: 38304627 PMC: 10828140. DOI: 10.1007/s10616-023-00603-0.

Engineering a replication-incompetent viral vector for the delivery of therapeutic RNA in crustaceans.

Alenton R, Mai H, Dhar A PNAS Nexus. 2023; 2(9):pgad278.

PMID: 37693213 PMC: 10485883. DOI: 10.1093/pnasnexus/pgad278.

Insect Cell-Based Models: Cell Line Establishment and Application in Insecticide Screening and Toxicology Research.

He X, Lu L, Huang P, Yu B, Peng L, Zou L Insects. 2023; 14(2).

PMID: 36835673 PMC: 9965340. DOI: 10.3390/insects14020104.

Orally Administrated Recombinant Vaccinia Virus Displaying ROP4 Induces Protection against Challenge Infection.

Yoon K, Chu K, Kang H, Kim M, Eom G, Quan F Vaccines (Basel). 2022; 10(2).

PMID: 35214611 PMC: 8878533. DOI: 10.3390/vaccines10020152.

References

Prehaud C, Takehara K, Flamand A, Bishop D . Immunogenic and protective properties of rabies virus glycoprotein expressed by baculovirus vectors. Virology. 1989; 173(2):390-9. DOI: 10.1016/0042-6822(89)90551-5. View

Gherardi M, Esteban M . Recombinant poxviruses as mucosal vaccine vectors. J Gen Virol. 2005; 86(Pt 11):2925-2936. DOI: 10.1099/vir.0.81181-0. View

Kool M, Voncken J, van Lier F, Tramper J, Vlak J . Detection and analysis of Autographa californica nuclear polyhedrosis virus mutants with defective interfering properties. Virology. 1991; 183(2):739-46. DOI: 10.1016/0042-6822(91)91003-y. View

Yoshida S, Kondoh D, Arai E, Matsuoka H, Seki C, Tanaka T . Baculovirus virions displaying Plasmodium berghei circumsporozoite protein protect mice against malaria sporozoite infection. Virology. 2003; 316(1):161-70. DOI: 10.1016/j.virol.2003.08.003. View

Delenda C, Frenkiel M, Deubel V . Protective efficacy in mice of a secreted form of recombinant dengue-2 virus envelope protein produced in baculovirus infected insect cells. Arch Virol. 1994; 139(1-2):197-207. DOI: 10.1007/BF01309465. View

Rosen E, Stapleton J, McLinden J . Synthesis of immunogenic hepatitis A virus particles by recombinant baculoviruses. Vaccine. 1993; 11(7):706-12. DOI: 10.1016/0264-410x(93)90253-t. View

Bielefeldt-Ohmann H, Beasley D, Fitzpatrick D, Aaskov J . Analysis of a recombinant dengue-2 virus-dengue-3 virus hybrid envelope protein expressed in a secretory baculovirus system. J Gen Virol. 1997; 78 ( Pt 11):2723-33. DOI: 10.1099/0022-1317-78-11-2723. View

Pijlman G, Roode E, Fan X, Roberts L, Belsham G, Vlak J . Stabilized baculovirus vector expressing a heterologous gene and GP64 from a single bicistronic transcript. J Biotechnol. 2005; 123(1):13-21. DOI: 10.1016/j.jbiotec.2005.10.022. View

Jaffray A, Shephard E, van Harmelen J, Williamson C, Williamson A, Rybicki E . Human immunodeficiency virus type 1 subtype C Gag virus-like particle boost substantially improves the immune response to a subtype C gag DNA vaccine in mice. J Gen Virol. 2004; 85(Pt 2):409-413. DOI: 10.1099/vir.0.19396-0. View

10.

Pande A, Carr B, Wong S, Dalton K, Jones I, McCauley J . The glycosylation pattern of baculovirus expressed envelope protein E2 affects its ability to prevent infection with bovine viral diarrhoea virus. Virus Res. 2005; 114(1-2):54-62. DOI: 10.1016/j.virusres.2005.05.011. View

11.

van Dijk A . Development of recombinant vaccines against bluetongue. Biotechnol Adv. 1993; 11(1):1-12. DOI: 10.1016/0734-9750(93)90407-e. View

12.

Brown C, Feijlbrief M, van Lent J, Spaan W . Chimeric parvovirus B19 capsids for the presentation of foreign epitopes. Virology. 1994; 198(2):477-88. DOI: 10.1006/viro.1994.1059. View

13.

Zintl A, Mulcahy G, Skerrett H, Taylor S, Gray J . Babesia divergens, a bovine blood parasite of veterinary and zoonotic importance. Clin Microbiol Rev. 2003; 16(4):622-36. PMC: 207107. DOI: 10.1128/CMR.16.4.622-636.2003. View

14.

Pekosz A, Griot C, Stillmock K, NATHANSON N . Protection from La Crosse virus encephalitis with recombinant glycoproteins: role of neutralizing anti-G1 antibodies. J Virol. 1995; 69(6):3475-81. PMC: 189060. DOI: 10.1128/JVI.69.6.3475-3481.1995. View

15.

Christensen J, Alexandersen S, Bloch B, Aasted B, Uttenthal A . Production of mink enteritis parvovirus empty capsids by expression in a baculovirus vector system: a recombinant vaccine for mink enteritis parvovirus in mink. J Gen Virol. 1994; 75 ( Pt 1):149-55. DOI: 10.1099/0022-1317-75-1-149. View

16.

Luo M, Yuan F, Liu Y, Jiang S, Song X, Jiang P . Induction of neutralizing antibody against human immunodeficiency virus type 1 (HIV-1) by immunization with gp41 membrane-proximal external region (MPER) fused with porcine endogenous retrovirus (PERV) p15E fragment. Vaccine. 2005; 24(4):435-42. DOI: 10.1016/j.vaccine.2005.08.006. View

17.

Quanquin N, Galaviz C, Fouts D, Wrightsman R, Manning J . Immunization of mice with a TolA-like surface protein of Trypanosoma cruzi generates CD4(+) T-cell-dependent parasiticidal activity. Infect Immun. 1999; 67(9):4603-12. PMC: 96784. DOI: 10.1128/IAI.67.9.4603-4612.1999. View

18.

Song C, Lee Y, Lee C, Sung H, Kim J, Mo I . Induction of protective immunity in chickens vaccinated with infectious bronchitis virus S1 glycoprotein expressed by a recombinant baculovirus. J Gen Virol. 1998; 79 ( Pt 4):719-23. DOI: 10.1099/0022-1317-79-4-719. View

19.

Brown C, van Lent J, Vlak J, Spaan W . Assembly of empty capsids by using baculovirus recombinants expressing human parvovirus B19 structural proteins. J Virol. 1991; 65(5):2702-6. PMC: 240632. DOI: 10.1128/JVI.65.5.2702-2706.1991. View

20.

Despres P, Dietrich J, Girard M, Bouloy M . Recombinant baculoviruses expressing yellow fever virus E and NS1 proteins elicit protective immunity in mice. J Gen Virol. 1991; 72 ( Pt 11):2811-6. DOI: 10.1099/0022-1317-72-11-2811. View